BG101554A - 14 алфа, 17 алфа-с долу 2-свързани 19-нор-прогестеронови производни - Google Patents
14 алфа, 17 алфа-с долу 2-свързани 19-нор-прогестеронови производниInfo
- Publication number
- BG101554A BG101554A BG101554A BG10155497A BG101554A BG 101554 A BG101554 A BG 101554A BG 101554 A BG101554 A BG 101554A BG 10155497 A BG10155497 A BG 10155497A BG 101554 A BG101554 A BG 101554A
- Authority
- BG
- Bulgaria
- Prior art keywords
- hydrogen
- alkyl residue
- atom
- hydrogen atom
- residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Новите съединения проявяват много висока гестагенова активност и са подходящи за получаването на лекарствени средства. Те имат обща формула вкоято R3 е кислороден атом, хидроксииминогрупа или два водородни атома; когато R6 е водороден, флуорен, хлорен или бромен атом или е - или -разположен С1-С4 алкилов остатък, R6' и R7 са водородни атоми, а когато R6 е водороден, флуорен, хлорен илибромен атом или е С1-С4 алкилов остатък, R6' и R7 са обща допълнителна връзка; когато R7 e - или -разположен С1-С4 алкилов остатък, R6 и R6' са водородни атоми или R6 и R7 заедно са - или -разположена метиленова група и R6' е водороден атом, или R6 и R6' заедно са етиленова или амиленова група иR7 е водороден атом; R9 и R10 винаги са водородниатоми или една обща връзка; R11 и R12 винаги са водородни атоми или една обща връзка; R13 е метилова или етилова група; R15 е водороден атом или С1-С3 алкилов остатък; R16 и R16' независимо един от друг са водороден атом или С1-С3 алкилов остатък, или С2-С4 алкенилов остатък, или заедно са С1-С3 алкилиденова група; или R15 и R16 заедно са една обща връзка, а R16' е водороден атом или С1-С3 алкилов остатък, или R15 и R16 заедно са един пръстен счастична формула, в която n има стойност 1 и 2 и Х означава метиленова група или кислороден атом; R16' е водороден атом; R171 e водороден атом или С1-С3 алкилов остатък, R172 е водород, С1-С3 алкилов остатък или С2-С4 алкенилов остатък; R171' и R172' винаги са водородни атоми или образуват една обща връзка;
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4447401A DE4447401A1 (de) | 1994-12-23 | 1994-12-23 | 14,17-C¶2¶-überbrückte Steroide |
| PCT/EP1995/005107 WO1996020209A2 (de) | 1994-12-23 | 1995-12-23 | 14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG101554A true BG101554A (bg) | 1998-09-30 |
| BG63274B1 BG63274B1 (bg) | 2001-08-31 |
Family
ID=6537601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101554A BG63274B1 (bg) | 1994-12-23 | 1997-06-03 | 14 алфа, 17 алфа-с долу 2-свързани 19-нор-прогестеронови производни |
Country Status (33)
| Country | Link |
|---|---|
| US (3) | US5827842A (bg) |
| EP (1) | EP0799238B1 (bg) |
| JP (1) | JPH10511379A (bg) |
| KR (1) | KR100400621B1 (bg) |
| CN (1) | CN1109689C (bg) |
| AR (1) | AR002263A1 (bg) |
| AT (1) | ATE193300T1 (bg) |
| AU (1) | AU692346B2 (bg) |
| BG (1) | BG63274B1 (bg) |
| CA (1) | CA2208605C (bg) |
| CZ (1) | CZ292696B6 (bg) |
| DE (2) | DE4447401A1 (bg) |
| DK (1) | DK0799238T3 (bg) |
| EE (1) | EE03356B1 (bg) |
| ES (1) | ES2151612T3 (bg) |
| FI (1) | FI972624A0 (bg) |
| GR (1) | GR3034261T3 (bg) |
| HU (1) | HUP0600457A2 (bg) |
| IL (1) | IL116504A (bg) |
| LT (1) | LT4295B (bg) |
| LV (1) | LV11954B (bg) |
| NO (1) | NO310198B1 (bg) |
| NZ (1) | NZ298770A (bg) |
| PL (1) | PL182642B1 (bg) |
| PT (1) | PT799238E (bg) |
| RO (1) | RO119366B1 (bg) |
| RU (1) | RU2169153C2 (bg) |
| SI (1) | SI9520137A (bg) |
| SK (1) | SK282281B6 (bg) |
| TW (1) | TW333536B (bg) |
| UA (1) | UA45382C2 (bg) |
| WO (1) | WO1996020209A2 (bg) |
| ZA (1) | ZA9510923B (bg) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3310301B2 (ja) * | 1996-09-03 | 2002-08-05 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | ビタミンｄおよびステロイド誘導体の合成用中間体およびその製造方法 |
| DE19848305C1 (de) * | 1998-10-14 | 2000-05-25 | Schering Ag | Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens |
| DE19848303A1 (de) * | 1998-10-14 | 2000-04-20 | Schering Ag | Kombination aus Gestagenen und Zuckern |
| EP1216699A1 (de) * | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
| DE102007063503A1 (de) | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3628189A1 (de) | 1986-08-20 | 1988-02-25 | Schering Ag | Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene |
| DE4326240A1 (de) | 1993-08-02 | 1995-02-09 | Schering Ag | 15,15-Dialkyl-substituierte Derivate des Estradiols |
-
1994
- 1994-12-23 DE DE4447401A patent/DE4447401A1/de not_active Withdrawn
-
1995
- 1995-12-21 ZA ZA9510923A patent/ZA9510923B/xx unknown
- 1995-12-22 AR ARP950100723A patent/AR002263A1/es unknown
- 1995-12-22 IL IL11650495A patent/IL116504A/en not_active IP Right Cessation
- 1995-12-23 KR KR1019970704251A patent/KR100400621B1/ko not_active IP Right Cessation
- 1995-12-23 SK SK788-97A patent/SK282281B6/sk unknown
- 1995-12-23 JP JP8520205A patent/JPH10511379A/ja not_active Ceased
- 1995-12-23 NZ NZ298770A patent/NZ298770A/en unknown
- 1995-12-23 WO PCT/EP1995/005107 patent/WO1996020209A2/de active IP Right Grant
- 1995-12-23 UA UA97073911A patent/UA45382C2/uk unknown
- 1995-12-23 EP EP95943195A patent/EP0799238B1/de not_active Expired - Lifetime
- 1995-12-23 EE EE9700142A patent/EE03356B1/xx not_active IP Right Cessation
- 1995-12-23 ES ES95943195T patent/ES2151612T3/es not_active Expired - Lifetime
- 1995-12-23 SI SI9520137A patent/SI9520137A/sl not_active IP Right Cessation
- 1995-12-23 CN CN95197047A patent/CN1109689C/zh not_active Expired - Fee Related
- 1995-12-23 RU RU97112100/04A patent/RU2169153C2/ru not_active IP Right Cessation
- 1995-12-23 HU HU0600457A patent/HUP0600457A2/hu not_active Application Discontinuation
- 1995-12-23 CZ CZ19971954A patent/CZ292696B6/cs not_active IP Right Cessation
- 1995-12-23 DE DE59508403T patent/DE59508403D1/de not_active Expired - Fee Related
- 1995-12-23 DK DK95943195T patent/DK0799238T3/da active
- 1995-12-23 PL PL95320799A patent/PL182642B1/pl not_active IP Right Cessation
- 1995-12-23 RO RO97-01062A patent/RO119366B1/ro unknown
- 1995-12-23 PT PT95943195T patent/PT799238E/pt unknown
- 1995-12-23 AU AU44338/96A patent/AU692346B2/en not_active Ceased
- 1995-12-23 AT AT95943195T patent/ATE193300T1/de not_active IP Right Cessation
- 1995-12-23 CA CA002208605A patent/CA2208605C/en not_active Expired - Fee Related
- 1995-12-26 US US08/578,847 patent/US5827842A/en not_active Expired - Fee Related
-
1996
- 1996-01-25 TW TW085100899A patent/TW333536B/zh not_active IP Right Cessation
-
1997
- 1997-06-03 BG BG101554A patent/BG63274B1/bg unknown
- 1997-06-18 FI FI972624A patent/FI972624A0/fi unknown
- 1997-06-20 LT LT97-106A patent/LT4295B/lt not_active IP Right Cessation
- 1997-06-20 LV LVP-97-125A patent/LV11954B/lv unknown
- 1997-06-23 NO NO19972927A patent/NO310198B1/no unknown
-
1998
- 1998-08-18 US US09/135,483 patent/US5973172A/en not_active Expired - Fee Related
-
1999
- 1999-07-28 US US09/362,214 patent/US6147065A/en not_active Expired - Fee Related
-
2000
- 2000-08-24 GR GR20000401948T patent/GR3034261T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL110091A (en) | POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BG103903A (bg) | Нестероидни (хетеро) циклични заместени ациланилиди със смесена гестагенна и андрогенна активности | |
| MY117783A (en) | Halogen substituted tetracyclic tetrahydrofuran derivatives | |
| ES8200011A1 (es) | Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. | |
| IT1256948B (it) | nuovi DERIVATI BENZOPIRANICI | |
| MY117092A (en) | Chemotherapeutic pyrrolocarbazole derivatives | |
| BG101554A (bg) | 14 алфа, 17 алфа-с долу 2-свързани 19-нор-прогестеронови производни | |
| TW324009B (en) | Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor | |
| EP0787000A4 (en) | CHINAZOLINONE MEDICINES AND THEIR USE | |
| IL98488A0 (en) | Oxazole derivatives,their preparation and pharmaceutical compositions containing them | |
| TW238304B (en) | A process for the preparation of 1-substituted-5(4H)-tetrazolinones | |
| MY117086A (en) | 3''-aziridino-anthracycline derivatives. | |
| WO2001046194A3 (en) | Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives | |
| HUP9903526A2 (hu) | Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények | |
| ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
| MY116271A (en) | Phenylsubstituted 4-azasteroid fluoroderivatives | |
| TR199902955T2 (xx) | Anjiogenez inhibit�r� tiadiazolil piridazin t�revleri. | |
| ES475596A1 (es) | Procedimiento para la preparacion de derivados de fenoxial- canolaminas | |
| HUP9802231A2 (hu) | Pirimidin-4-on-származékok, intermedierek, előállításuk és alkalmazásuk, valamint a vegyületeket hatóanyagként tartalmazó herbicid készítmények | |
| AU559732B2 (en) | Di-and-tetrahydroguinolylacetic acid esters | |
| ES8105319A1 (es) | Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas | |
| MX9700712A (es) | Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que los contienen. | |
| NZ216922A (en) | 6-amino-androsta-1,4-diene-3,17-dione derivatives and pharmaceutical compositions | |
| BG108423A (bg) | Дихидроимидазо[5,1-а]-бета-карболинови производни, метод за тяхното получаване и използване като лекарствено средство | |
| AU1420792A (en) | New sulphonamides, process for preparing the same and medicaments containing these compounds |